After controlling for known CV risk factors, all FFR-CT subgroups remained significantly associated with MI, revascularization. (HealthDay News) — For patients with coronary artery disease (CAD), ...

A routine strategy that assesses function of all epicardial vessels at the time of diagnostic angiography in patients with new-onset chest pain doesn’t cost any more than conventional diagnostic ...

The PLATFORM trial is a prospective, consecutive cohort study into which researchers enrolled patients with new-onset chest pain and suspected CAD for which noninvasive or invasive assessment had been ...

Reliance on CTA-derived FFR produced more perfectly patent grafts than QCA ...

Please provide your email address to receive an email when new articles are posted on . Implementing a CT angiography-derived fractional flow reserve program improved certain outcomes in patients with ...

The company conducted a search of the health economics literature on HeartFlow FFR CT and the comparators specified in the decision problem. They identified a total of 174 studies, 24 of which it ...

Please provide your email address to receive an email when new articles are posted on . Abnormal FFR-CT findings were significantly prognostic of poor long-term outcomes in patients with stable angina ...

Doctors have traditionally relied on an invasive procedure known as invasive coronary angiography to image vessels and more recently have added other invasive tests like fractional flow reserve (FFR) ...

The $1.5 billion health-tech startup HeartFlow has a noninvasive test for coronary artery disease based on machine learning analysis of CT scans of the heart. It also has a large pile of money to run ...

An advanced CT test can identify individuals with stable angina at a reduced risk of three-year adverse outcomes despite their having a high coronary artery calcium score, according to a new study. An ...

Cedars-Sinai investigators and colleagues have developed an artificial intelligence (AI) tool that uses computed tomography (CT) scans to identify patients at risk of reduced blood flow to the heart.

The company's claimed system benefits included reduced costs from fewer inconclusive or inaccurate diagnostic tests and avoidance of unnecessary staff and procedure costs. It claimed that this would ...